Early initiation of antiretroviral therapy does not provide significant cardiovascular benefits compared with delayed initiation in people living with HIV who have high CD4+ counts.
Our data demonstrates that among patients initiating therapy in RLS with (mainly) an NNRTI-based regimen, CD4 cell count recovery is impaired in the presence of on-going HIV-RNA replication over an 18 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback